Literature DB >> 9037387

Localization of glycosaminoglycans and CD44 in the human lacrimal gland.

K Yoshida1, Y Nitatori, Y Uchiyama.   

Abstract

Recent analyses of tears indicate the presence of glycosaminoglycans as their components, but their origin remains unknown. To further understand the origin of these tear components, we investigated by immunohistochemical techniques the localization of glycosaminoglycans and CD44 human lacrimal glands obtained from 20 cadavers at autopsy. Monoclonal antibodies to CD44, a receptor for hyaluronic acid, dermatan sulfate, chondroitin sulfate, and keratan sulfate were applied to the tissue. Hyaluronic acid binding region was also used for the staining of hyaluronic acid. By light microscopy, immunoreactivity for CD44 was mostly detected on the baso-lateral membrane of acinar and ductal cells, and the vascular endothelium in the interstitium. Positive staining of hyaluronic acid was associated intensely with the basal membrane of acinar and ductal cells and weakly, faintly or not at all with their lateral membrane. Positive staining of hyaluronic acid and immunoreactivity for dermatan sulfate were detected in interstitial fibrous structures; particularly, the former was intense in the perivascular fibrous structures, and the latter along the periparenchimal fibrous structures. Immunoreactivity for chondroitin sulfate and keratan sulfate was seen in some acinar cells and the acinar and ductal lumen. By electron microscopy, immunogold particles indication chondroitin sulfate sulfate or keratan sulfate labeled secretory granules of the acinar cells. Considering the fact that CD44 is a receptor molecule for hyaluronic acid, the association of hyaluronic acid with the basal membrane and weakly or faintly with the lateral membrane of acinar and ductal cells may be attributed to the expression of CD44 on the baso-lateral membrane of the cells. Moreover, the presence of immunoreactivity for chondroitin sulfate and keratan sulfate in secretory granules of acinar cells and their lumens suggests that tears from the lacrimal gland contain these glycosaminoglycans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9037387     DOI: 10.1679/aohc.59.505

Source DB:  PubMed          Journal:  Arch Histol Cytol        ISSN: 0914-9465


  6 in total

1.  Generation of 3D lacrimal gland organoids from human pluripotent stem cells.

Authors:  Ryuhei Hayashi; Toru Okubo; Yuji Kudo; Yuki Ishikawa; Tsutomu Imaizumi; Kenji Suzuki; Shun Shibata; Tomohiko Katayama; Sung-Joon Park; Robert D Young; Andrew J Quantock; Kohji Nishida
Journal:  Nature       Date:  2022-04-20       Impact factor: 49.962

2.  Iodide protection from UVB irradiation-induced degradation of hyaluronate and against UVB-damage of human conjunctival fibroblasts.

Authors:  Otto Schmut; Jutta Horwath-Winter; Gebhard Rieger; Rudolf Winkler; Gabriele Trummer; Helga Spitzenberger; Christa Wachswender
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-16       Impact factor: 3.117

3.  Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome.

Authors:  Katja Schenke-Layland; Jiansong Xie; Ekaterini Angelis; Barry Starcher; Kaijin Wu; Iris Riemann; W Robb MacLellan; Sarah F Hamm-Alvarez
Journal:  Matrix Biol       Date:  2007-07-17       Impact factor: 11.583

4.  Quantitative determination of glycosaminoglycans in tears of diabetic patients.

Authors:  Marilita M Moschos; Alexandros A Rouvas; Spyridon Papadimitriou; Athanasios Kotsolis; Nikolaos Sitaras; Michael Apostolopoulos
Journal:  Clin Ophthalmol       Date:  2008-09

5.  Novel Artificial Tears Containing Cross-Linked Hyaluronic Acid: An In Vitro Re-Epithelialization Study.

Authors:  Arianna Fallacara; Silvia Vertuani; Giacomo Panozzo; Alessandra Pecorelli; Giuseppe Valacchi; Stefano Manfredini
Journal:  Molecules       Date:  2017-11-30       Impact factor: 4.411

6.  Efficacy of eye drops containing crosslinked hyaluronic acid and CoQ10 in restoring ocular health exposed to chlorinated water.

Authors:  Costanza Tredici; Romina Fasciani; Antonio Villano; Gloria Gambini; Aldo Caporossi
Journal:  Eur J Ophthalmol       Date:  2020-02-16       Impact factor: 2.597

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.